Post-translational control of chemokines: a role for decoy receptors?
- PMID: 15585320
- DOI: 10.1016/j.imlet.2004.08.018
Post-translational control of chemokines: a role for decoy receptors?
Abstract
It is well-established that chemokines play a critical role in the orchestration of inflammation and immunity. Interactions between chemokines and their receptors are essential for the homing of specific subsets of leukocytes to their functional microenvironments. They also influence other diverse biological processes such as development, leukocyte activation, Th1/Th2 polarisation, tumour metastasis, angiogenesis, and HIV pathogenesis. However, despite their importance, only now are we beginning to understand the complex regulation brought to bear on these molecules. In this review, we discuss a number of these key chemokine regulators that exert their influence once these proteins have been synthesised. We examine (i) chemokine storage, release, and presentation, (ii) protease regulation, (iii) viral manipulation of host chemokines, and (iv) natural mammalian receptor antagonists. Principally, the growing evidence for a role for decoy receptors in the chemokine system is discussed. In particular, the potential decoy function of the 'silent' pro-inflammatory chemokine receptor D6 is described alongside two other candidate decoy receptor molecules, DARC, and CCX-CKR. Dissecting the biological and pathological function of these chemokine controllers will lead to a deeper understanding of chemokine regulation, and may reveal novel strategies to therapeutically modify the chemokine system.
Similar articles
-
Chemokine-receptor interactions: GPCRs, glycosaminoglycans and viral chemokine binding proteins.Adv Protein Chem. 2004;68:351-91. doi: 10.1016/S0065-3233(04)68010-7. Adv Protein Chem. 2004. PMID: 15500866 Review.
-
Regulation of chemotactic networks by 'atypical' receptors.Bioessays. 2007 Mar;29(3):237-47. doi: 10.1002/bies.20537. Bioessays. 2007. PMID: 17295321 Review.
-
Chemokine sequestration by atypical chemokine receptors.Biochem Soc Trans. 2006 Dec;34(Pt 6):1009-13. doi: 10.1042/BST0341009. Biochem Soc Trans. 2006. PMID: 17073739 Review.
-
Regulation of chemokine activity by posttranslational modification.Pharmacol Ther. 2008 Nov;120(2):197-217. doi: 10.1016/j.pharmthera.2008.08.006. Epub 2008 Aug 28. Pharmacol Ther. 2008. PMID: 18793669 Review.
-
Chemokines and chemokine receptors in HIV infection: role in pathogenesis and therapeutics.J Postgrad Med. 2006 Jul-Sep;52(3):210-7. J Postgrad Med. 2006. PMID: 16855325 Review.
Cited by
-
Chemokine Signatures of Pathogen-Specific T Cells I: Effector T Cells.J Immunol. 2020 Oct 15;205(8):2169-2187. doi: 10.4049/jimmunol.2000253. Epub 2020 Sep 18. J Immunol. 2020. PMID: 32948687 Free PMC article.
-
A recombinant dromedary antibody fragment (VHH or nanobody) directed against human Duffy antigen receptor for chemokines.Cell Mol Life Sci. 2010 Oct;67(19):3371-87. doi: 10.1007/s00018-010-0387-6. Epub 2010 May 11. Cell Mol Life Sci. 2010. PMID: 20458517 Free PMC article.
-
Association between ABO and Duffy blood types and circulating chemokines and cytokines.Genes Immun. 2021 Jul;22(3):161-171. doi: 10.1038/s41435-021-00137-5. Epub 2021 Jun 8. Genes Immun. 2021. PMID: 34103707 Free PMC article. Clinical Trial.
-
Inhibition of CXCR3-mediated chemotaxis by the human chemokine receptor-like protein CCX-CKR.Br J Pharmacol. 2013 Mar;168(6):1375-87. doi: 10.1111/bph.12042. Br J Pharmacol. 2013. PMID: 23121557 Free PMC article.
-
Monocyte chemoattractant protein 1, macrophage inflammatory protein 1 alpha, and RANTES recruit macrophages to the kidney in a mouse model of hemolytic-uremic syndrome.Infect Immun. 2007 Mar;75(3):1229-36. doi: 10.1128/IAI.01663-06. Epub 2007 Jan 12. Infect Immun. 2007. PMID: 17220320 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources